PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))

[(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

YWVSCSFOXQDMHS-MOZFSHPBSA-N CHEBI:190165 0 Reactome links 1 studies

Metabolite details

Identifier: YWVSCSFOXQDMHS-MOZFSHPBSA-N
InChI Key: YWVSCSFOXQDMHS-MOZFSHPBSA-N
IUPAC name: [(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
Preferred name: PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
INN name: —
Synonym: —
ChEBI: CHEBI:190165

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)

Observed in differential profiles

4_weeks_vs_52_weeks